This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2024 Nov 6;14(11):596.

doi: 10.3390/metabo14110596.

The Role of Lipid Metabolism in Dyslipidemias and Atherosclerosis

Miodrag Janić^{1

2

3}, Shizuya Yamashita⁴, Ta-Chen Su⁵, Manfredi Rizzo^{3

6}

Affiliations

Affiliations

¹ Department of Endocrinology, Diabetes and Metabolic Diseases, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia.
² Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia.
³ Department of Internal Medicine and Medical Specialties, School of Medicine, University of Palermo, 90133 Palermo, Italy.
⁴ Department of Cardiology, Rinku General Medical Center, Rinku Ourai Kita 2-23, Osaka 598-8577, Japan.
⁵ Departments of Environmental and Occupational Medicine and Internal Medicine, National Taiwan University College of Medicine, National Taiwan University Hospital, Taipei 10617, Taiwan.
⁶ College of Pharmacy, Ras Al Khaimah Medical and Health Sciences University, Ras Al Khaimah 11172, United Arab Emirates.

PMID: 39590832
PMCID: PMC11596138
DOI: 10.3390/metabo14110596

Editorial

The Role of Lipid Metabolism in Dyslipidemias and Atherosclerosis

Miodrag Janić et al. Metabolites. 2024.

. 2024 Nov 6;14(11):596.

doi: 10.3390/metabo14110596.

Authors

Miodrag Janić^{1

2

3}, Shizuya Yamashita⁴, Ta-Chen Su⁵, Manfredi Rizzo^{3

6}

Affiliations

¹ Department of Endocrinology, Diabetes and Metabolic Diseases, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia.
² Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia.
³ Department of Internal Medicine and Medical Specialties, School of Medicine, University of Palermo, 90133 Palermo, Italy.
⁴ Department of Cardiology, Rinku General Medical Center, Rinku Ourai Kita 2-23, Osaka 598-8577, Japan.
⁵ Departments of Environmental and Occupational Medicine and Internal Medicine, National Taiwan University College of Medicine, National Taiwan University Hospital, Taipei 10617, Taiwan.
⁶ College of Pharmacy, Ras Al Khaimah Medical and Health Sciences University, Ras Al Khaimah 11172, United Arab Emirates.

PMID: 39590832
PMCID: PMC11596138
DOI: 10.3390/metabo14110596

Abstract

Atherosclerotic cardiovascular disease is a major burden of morbidity and, despite recent therapeutic advances, is the leading cause of mortality worldwide [...].

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the report in this manuscript.

References

1. Esmaeili P., Roshanravan N., Ghaffari S., Mesri Alamdari N., Asghari-Jafarabadi M. Unraveling atherosclerotic cardiovascular disease risk factors through conditional probability analysis with Bayesian networks: Insights from the AZAR cohort study. Sci. Rep. 2024;14:4361. doi: 10.1038/s41598-024-55141-2. - DOI - PMC - PubMed
1. Silverman M.G., Ference B.A., Im K., Wiviott S.D., Giugliano R.P., Grundy S.M., Braunwald E., Sabatine M.S. Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis. JAMA. 2016;316:1289–1297. doi: 10.1001/jama.2016.13985. - DOI - PubMed
1. Mazhar F., Hjemdahl P., Clase C.M., Johnell K., Jernberg T., Sjolander A., Carrero J.J. Intensity of and Adherence to Lipid-Lowering Therapy as Predictors of Major Adverse Cardiovascular Outcomes in Patients With Coronary Heart Disease. J. Am. Heart Assoc. 2022;11:e025813. doi: 10.1161/JAHA.122.025813. - DOI - PMC - PubMed
1. Chary A., Hedayati M. Review of Laboratory Methods to Determine HDL and LDL Subclasses and Their Clinical Importance. Rev. Cardiovasc. Med. 2022;23:147. doi: 10.31083/j.rcm2304147. - DOI - PMC - PubMed
1. Muzurovic E., Borozan S., Rizzo M. Clinical impact of genetic testing for lipid disorders. Curr. Opin. Cardiol. 2024;39:154–161. doi: 10.1097/HCO.0000000000001133. - DOI - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- MDPI
- PubMed Central